V1rg10 Activators
Vomeronasal 1 receptor, G10 activators are compounds that either directly or indirectly enhance the functional activity of this receptor through various signaling mechanisms. Adenylate cyclase activator Forskolin and cAMP analog 8-Bromo-cAMP elevate intracellular cAMP levels, which activates PKA. The activation of PKA is a critical step in the phosphorylation of target proteins in the vomeronasal 1 receptor, G10 signaling pathway, thus enhancing its functional activity. Similarly, Phosphodiesterase inhibitors like Ibuprofen increase cAMP levels by preventing its breakdown, thereby indirectly enhancing the signaling cascade of vomeronasal 1 receptor, G10. G protein activators such as Mastoparan exert their effect by directly stimulating G proteins, which are pivotal in the signal transduction of the vomeronasal 1 receptor, G10, promoting its activation.
Calcium plays a vital role in the signaling pathways associated with the vomeronasal 1 receptor, G10. Compounds like A23187 and SN-6 manipulate intracellular calcium levels, with A23187 acting as an ionophore to increase calcium influx, and SN-6 inhibiting the sodium/calcium exchanger to prevent calcium efflux. These changes in calcium concentrations can activate calcium-dependent kinases, which then enhance the receptor's signaling pathway. IP3 receptor agonists, such as Adenophostin A, trigger the release of calcium from intracellular stores, further potentiating the receptor's activity. Similarly, diacylglycerol (DAG) analogs like OAG activate PKC, which can phosphorylate proteins within the vomeronasal 1 receptor, G10 signaling cascade, leading to its activation. Nitric oxide donors such as Sodium nitroprusside contribute to signaling by donating nitric oxide, which activates guanylate cyclase, increasing cGMP levels and activating cGMP-dependent kinases that can enhance the receptor's signaling mechanisms. cGMP analogs like 8-Bromo-cGMP also raise intracellular cGMP levels, thus activating kinases and enhancing the functional activity of the receptor.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP serves as a cell-permeable analog of cAMP, bypassing adenylate cyclase activation. It activates PKA, which can lead to phosphorylation events that enhance the activation of the vomeronasal 1 receptor, G10 signaling pathway. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Ibuprofen, apart from its anti-inflammatory action, can inhibit phosphodiesterase, leading to increased cAMP levels. Elevated cAMP activates PKA, which in turn can enhance the signaling pathways of vomeronasal 1 receptor, G10. | ||||||
Mastoparan | 72093-21-1 | sc-200831 | 1 mg | $99.00 | ||
Mastoparan is a peptide that directly stimulates G proteins. By activating G proteins, mastoparan can enhance the intracellular signaling cascade of vomeronasal 1 receptor, G10, leading to its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate various proteins within the signal transduction pathways. PKC activation can enhance signaling events downstream of vomeronasal 1 receptor, G10, leading to its functional activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium concentrations, which can activate calcium-dependent protein kinases. These kinases may enhance the signaling transduction pathway of vomeronasal 1 receptor, G10. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
OAG mimics the action of DAG, activating PKC. Activated PKC can then enhance the signaling cascades involving vomeronasal 1 receptor, G10, leading to its functional activation. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable GTP analog that activates G proteins. By activating G proteins, it enhances the signal transduction pathways of vomeronasal 1 receptor, G10. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium nitroprusside releases nitric oxide which can activate guanylate cyclase, increasing cGMP levels. Elevated cGMP can contribute to the activation of signaling pathways related to vomeronasal 1 receptor, G10. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Bromo-cGMP serves as a cell-permeable cGMP analog and can activate cGMP-dependent protein kinases. These kinases can enhance signaling pathways in which vomeronasal 1 receptor, G10 is involved. | ||||||